EDGAR Filing Documents for 9999999995-21-001639

Form EFFECT - Notice of Effectiveness:

SEC Accession No. 9999999995-21-001639

Accepted

2021-05-03 00:15:10

Documents

Effectiveness Date

2021-04-30

Registration Form

POS AM

Reference AccNo

0001104659-21-055818

Document Format Files

Seq	Description	Document	Type	Size
1		primary_doc.html	EFFECT
1		primary_doc.xml	EFFECT	605
	Complete submission text file	9999999995-21-001639.txt		1905

Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018

Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702

Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: EFFECT | Act: 33 | File No.: 333-227752 | Film No.: 21881042
SIC: 2834 Pharmaceutical Preparations